Domainex appoints Dr Bodo Spori
Domainex Ltd, a privately-owned drug discovery services company, has announced the appointment of Dr Bodo Spori as Head of Business Development for Europ.
Bodo Spori is a German neuroscientist, born and raised in Belgium, with more than 13 years of experience in strategic business development roles. He joins Domainex from Cyprotex, a subsidiary of Evotec AG, where he oversaw European and global sales initiatives in his role as VP of Business Development.
Established in 2001 as a spin-out from University College London, Birkbeck College, and the Institute of Cancer Research, Domainex Ltd. is a Cambridge-based, privately-owned company that provides integrated medicines research services to global pharmaceutical, biotechnology and academic partners.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium